Upgrade MP Materials to Hold for defensive rare earth exposure: NdPr production ramps as prices rise, with limited downside amid macro/geopolitical risks.
A $2.5 billion valuation in biotech isn’t just about current sales; it’s heavily weighted towards future potential, clinical ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果